Telferscot Resources issued the press release below on April 5, 2018:

Telferscot Resources Inc. (CSE:TFS) (“Telferscot” or the “Company“) issues correction to April 3, 2018 release regarding figures for the shares distributed to Telferscot shareholders under the Company’s Plan of Arrangement.


Please see the following CORRECTED number of shares to be received by shareholders of Telferscot:

For every 1,000 shares of Telferscot owned as of the Record Date (above), Telferscot shareholders will receive:

  • 100 shares of SpinCo #1
  • 20 shares of SpinCo #2 **
  • 20 shares of SpinCo #3 **
  • 20 shares of SpinCo #4 **
  • 100 shares of SpinCo #5
  • 20 shares of SpinCo #6 **
  • 200 shares of SpinCo #7

** Figures have been corrected, due to a typographical error, not due to any changes in the Company’s plans.

None of these companies are currently listed for trading on any exchange and as such, the shares are not currently readily saleable. It is the intention of six of the seven companies to complete the planned acquisitions of business as outlined in the Management Information Circular dated March 1, 2018 and available at www.tfs-poa.com. The seventh company, SpinCo #7, will continue to pursue the Company’s legal action against Auxico Resources Canada Inc.

For complete information on the Plan of Arrangement and the acquisition to Canntab Therapeutics, investors and shareholders are encouraged to go to www.tfs-poa.com. Investors can sign up there to receive investor communications on the activities of Canntab as well as plans and developments in each of the new entities to be distributed to shareholders.

About Telferscot Resources Inc.

Telferscot Resources Inc. is a Canadian company listed on the CSE under ticker symbol TFS. For further information and access to the Company’s public disclosure record please consult SEDAR at www.sedar.com or the Canadian Securities Exchange at www.thecse.com.

Click here to connect with Canntab Therapeutics Limited for an Investor Presentation

Original press release published on April 4, 2018:

Telferscot Resources Inc. (CSE:TFS) (“Telferscot” or the “Company”) is pleased to announce that the Company has received confirmation from the Canadian Securities Exchange of approval of the listing of the common shares of Canntab Therapeutics Limited (“Canntab”) subject to completion of the transactions as described in the listing statement and completion of any and all outstanding CSE documentation and fee payments.

Additionally, the Company is pleased to inform shareholders and investors that the shareholders of Canntab have approved the acquisition of Canntab by Telferscot as detailed in the Company’s Management Information Circular.

It is anticipated that the transaction will close on or about April 9, 2018. At which point, Telferscot shares will be exchanged for new shares of Canntab on a ratio of 1 new Canntab share for every 200 current Telferscot shares.

Following closing of the transaction and subject to any approvals by the Canadian Securities Exchange and Regulators, Canntab shares will commence trading on the CSE under the trading symbol: “PILL”

For information on the transaction as well as the Telferscot Plan of Arrangement — the distribution of new company shares to Telferscot shareholders, please go to www.tfs-poa.com. Investors can sign up there to receive news and investor communications on the activities of Canntab as well as plans and developments in each of the new entities to be distributed to shareholders.

About Canntab Therapeutics Limited

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extracted from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab’s mission is to put the “Medical” into medicinal cannabis!

About Telferscot Resources Inc.

Telferscot Resources Inc. is a Canadian company listed on the CSE under ticker symbol TFS. For further information and access to the Company’s public disclosure record please consult SEDAR at www.sedar.com or the Canadian Securities Exchange at www.thecse.com.

Click here to connect with Canntab Therapeutics Limited for an Investor Presentation

Source: www.newsfilecorp.com

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less